PharmaSGP Holding SE

XETRA PSG.DE

PharmaSGP Holding SE Cash and Short-Term Investments for the year ending December 31, 2023: USD 45.00 M

PharmaSGP Holding SE Cash and Short-Term Investments is USD 45.00 M for the year ending December 31, 2023, a 24.12% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • PharmaSGP Holding SE Cash and Short-Term Investments for the year ending December 31, 2022 was USD 36.25 M, a 52.93% change year over year.
  • PharmaSGP Holding SE Cash and Short-Term Investments for the year ending December 31, 2021 was USD 23.71 M, a 142.54% change year over year.
  • PharmaSGP Holding SE Cash and Short-Term Investments for the year ending December 31, 2020 was USD 9.77 M.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
XETRA: PSG.DE

PharmaSGP Holding SE

CEO Ms. Natalie Weigand
IPO Date June 19, 2020
Location Germany
Headquarters Lochhamer Schlag 21
Employees 89
Sector Healthcare
Industries
Description

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

Similar companies

SBS.DE

Stratec SE

USD 38.08

2.78%

AJ91.DE

DocCheck AG

USD 9.05

-0.32%

OHB.DE

OHB SE

USD 60.76

2.71%

DMP.DE

Dermapharm Holding SE

USD 40.73

-0.51%

M7U.DE

Nynomic AG

USD 18.62

-1.40%

StockViz Staff

February 7, 2025

Any question? Send us an email